Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-13

Clinical Trial Update: PREvention of STroke in Intracerebral haemorrhaGE Survivors With Atrial Fibrillation [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating stroke prevention in patients with atrial fibrillation who survived intracerebral hemorrhage has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Imperial College London | Conditions: Atrial Fibrillation, Intracerebral Hemorrhage | Phase 3 | Status: COMPLETED